[ESPR] YoY Quarter Result on 31-Mar-2017 [#Q1]

Stock
[ESPR] Esperion Therapeutics, Inc.
Announcement Date
04-May-2017
Financial Year
2017
Quarter
31-Mar-2017 [#Q1]
Profit Trend
QoQ- -40.01%
YoY- -177.96%
Quarter Report
ESPR's Result
ESPR's Financial Summary
View:
Show?
Quarter Result
31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 CAGR
Revenue 1,840 145,419 0 0 0 0 0 -
PBT -78,249 87,379 -46,130 -40,541 -14,585 -11,466 -7,874 46.57%
Tax 4,539 0 0 482 457 227 16 156.11%
NP -78,249 87,379 -46,130 -40,541 -14,585 -11,466 -7,874 46.57%
Tax Rate - 0.00% - - - - - -
Total Cost 80,089 58,040 46,130 40,541 14,585 11,466 7,874 47.14%
Ratio Analysis
31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 CAGR
NP Margin -4,252.66 60.09 0.00 0.00 0.00 0.00 0.00 -
Per Share
31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 CAGR
EPS -2.84 3.26 -1.73 -1.80 -0.65 -0.56 -0.51 33.09%
EPS Diluted -2.84 3.07 -1.73 -1.80 -0.65 -0.56 -0.51 33.09%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.